Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Roche launches innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity: Basel Wednesday, May 7, 2025, 10:00 Hrs [IST] Roche announced the launch ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

The Prime Minister finally has a new chief science adviser, almost a year after his former adviser stepped down. Ministry of ...

As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...